Your browser doesn't support javascript.
loading
SLFN11 biomarker status predicts response to lurbinectedin as a single agent and in combination with ATR inhibition in small cell lung cancer.
Kundu, Kiran; Cardnell, Robert J; Zhang, Bingnan; Shen, Li; Stewart, C Allison; Ramkumar, Kavya; Cargill, Kasey R; Wang, Jing; Gay, Carl M; Byers, Lauren A.
Afiliação
  • Kundu K; Department of Thoracic/Head and Neck Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA.
  • Cardnell RJ; Department of Thoracic/Head and Neck Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA.
  • Zhang B; Division of Cancer Medicine, UT MD Anderson Cancer Center, Houston, TX, USA.
  • Shen L; Department of Bioinformatics and Computational Biology, UT MD Anderson Cancer Center, Houston, TX, USA.
  • Stewart CA; Department of Thoracic/Head and Neck Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA.
  • Ramkumar K; Department of Thoracic/Head and Neck Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA.
  • Cargill KR; Department of Thoracic/Head and Neck Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA.
  • Wang J; Department of Bioinformatics and Computational Biology, UT MD Anderson Cancer Center, Houston, TX, USA.
  • Gay CM; Department of Thoracic/Head and Neck Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA.
  • Byers LA; Department of Thoracic/Head and Neck Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA.
Transl Lung Cancer Res ; 10(11): 4095-4105, 2021 Nov.
Article em En | MEDLINE | ID: mdl-35004241

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article